+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global High-flow Nasal Cannula Market by Component (Active Humidifier, Air Oxygen Blender, Heated Inspiratory Circuit), Indication (Acute Heart Failure, Acute Respiratory Failure, Bronchiectasis), End User - Forecast 2024-2030- Product Image
Global High-flow Nasal Cannula Market by Component (Active Humidifier, Air Oxygen Blender, Heated Inspiratory Circuit), Indication (Acute Heart Failure, Acute Respiratory Failure, Bronchiectasis), End User - Forecast 2024-2030- Product Image
Sale

Global High-flow Nasal Cannula Market by Component (Active Humidifier, Air Oxygen Blender, Heated Inspiratory Circuit), Indication (Acute Heart Failure, Acute Respiratory Failure, Bronchiectasis), End User - Forecast 2024-2030

  • PDF Icon

    Report

  • 192 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5532778
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The High-flow Nasal Cannula Market size was estimated at USD 3.11 billion in 2023, USD 3.38 billion in 2024, and is expected to grow at a CAGR of 9.17% to reach USD 5.76 billion by 2030.

The market for high-flow nasal cannulas includes medical devices and accessories used to deliver adequately heated and humidified medical gas at a variety of flows up to 60 liters per minute. HFNC therapy devices are primarily used in clinical settings for patients suffering from acute respiratory failure, chronic obstructive pulmonary disease (COPD), and other respiratory illnesses. The rising incidence of respiratory diseases worldwide and growing awareness of the benefits of HFNC therapy are significantly increasing the demand for high-flow nasal cannulas.

However, the high costs associated with procuring and operating HFNC devices can be a significant barrier, especially in cost-sensitive markets. Additionally, stringent regulatory requirements for medical devices can impede market entry and slow product launch times. Furthermore, technological advancements and the development of portable and home-use HFNC devices can offer significant growth opportunities for the market growth.

Regional Insights

The Americas region has significant usage of HFNC devices due to the high prevalence of Chronic Obstructive Pulmonary Disease (COPD) and other respiratory illnesses. Customer purchasing behavior tends to prioritize quality and efficacy, with a willingness to invest in premium devices. The presence of leading manufacturers and well-established healthcare facilities contributes to the high adoption rates in the region. The Asia Pacific region has been marked by robust growth in the healthcare sector, particularly in response to the rising prevalence of chronic respiratory diseases.

Countries such as China, Japan, and India have witnessed a notable increase in consumer demand for advanced respiratory support devices, including high-flow nasal cannula (HFNC). This growth is driven by the aging population, rising pollution levels, and healthcare spending. Europe continues to show strong demand for HFNC devices, driven by a well-developed healthcare system and increased healthcare expenditure. EU countries possess strict regulations and high standards for medical devices, making market entry challenging but ensuring high-quality products. The Middle East and Africa (MEA) have varied market dynamics, with the Middle East exhibiting rising investments in healthcare infrastructure and increasing adoption of advanced medical technologies, while Africa's HFNC market is at a nascent stage but expected to grow due to the rising need for respiratory solutions.

Market Trends by Segment

  • Component: significant adoption of air oxygen blenders to provide critical functionality of precisely adjusting oxygen levels
  • End User: Growing use of high-flow nasal cannula in hospitals for supporting a wide range of patients and clinical scenarios

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

New Bronchiolitis Trial Launched to Seek The Best Breathing Support For Babies

A novel clinical trial has been initiated to ascertain the most effective respiratory assistance techniques for infants suffering from bronchiolitis. This condition, a common respiratory illness affecting babies, can cause significant breathing challenges. The trial aims to evaluate the efficacy of high-flow nasal cannula (HFNC) therapy, which delivers a blend of air and oxygen through small tubes inserted into the nostrils at a high flow rate.

Telesair Secures FDA Nod For Bonhawa Flow Oxygen Therapy System

Telesair unveiled the Bonhawa Flow Oxygen Therapy System, a state-of-the-art high-flow nasal cannula (HFNC) solution. This cutting-edge system is meticulously designed to enhance patient comfort and improve clinical outcomes in oxygen therapy applications. The Bonhawa Flow offers precision in delivering warmed and humidified oxygen, crucial for effective therapeutic interventions for patients experiencing respiratory distress. This expansion in the respiratory care market underscores the ongoing commitment to developing technologies that aid in managing respiratory conditions more effectively and reaffirms the potential for improved patient care standards and positive impacts on treatment efficacy across healthcare settings.

Mercy Flights Implementing High-Flow Nasal Cannula for High-Risk Respiratory Illness

Mercy Flights has advanced its respiratory care services by incorporating High-Flow Nasal Cannula (HFNC) therapy for patients facing severe respiratory illnesses. This state-of-the-art oxygen delivery system significantly enhances patient comfort and oxygenation by delivering heated, humidified air at a high flow rate, ensuring optimal respiratory support during transit. HFNC is particularly beneficial for patients suffering from conditions such as pneumonia, chronic obstructive pulmonary disease (COPD), and congestive heart failure, where traditional oxygen therapy may fall short.

Key Company Profiles

The report delves into recent significant developments in the High-flow Nasal Cannula Market, highlighting leading vendors and their innovative profiles. These include Allied Medical Limited, Armstrong Medical Limited, BMC Medical Co., Ltd., Drägerwerk AG & Co. KGaA, Fairmont Medical Products Pty Ltd., Fisher & Paykel Healthcare Corporation Limited, Flexicare (Group) Limited, Great Group Medical Co., Ltd., Guangdong Pigeon Medical Apparatus Co.,Ltd., Hamilton Medical AG, Heka Medicals India Private Limited, ICU Medical, Inc., Koninklijke Philips N.V., Masimo Corporation, MEKICS Co., Ltd., Narang Medical Limited, nice Neotech Medical Systems Pvt. Ltd., ResMed, Inc., Sterimed Group, SunMed, LLC, Synergy Intact Private Limited, Teleflex Incorporated, Vapotherm, Inc., Vyaire Medical, Inc., and Well Lead Medical Co., Ltd.

This research report offers invaluable insights into various crucial aspects of the High-flow Nasal Cannula Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Prevalence of Acute Respiratory Failures and Sleep Apnea
5.1.1.2. Increasing Utilization of HFNC in the Treatment of Bronchitis and Pneumonia Among Children
5.1.1.3. Rising need for Non-Invasive Ventilation and Continuous Positive Airway Pressure in Home Care Settings
5.1.2. Restraints
5.1.2.1. Relatively High Cost Compared to Traditional Cannula
5.1.3. Opportunities
5.1.3.1. Technological Advancements in High-Flow Nasal Cannula
5.1.3.2. Favorable Regulatory Framework Supporting Commercialization
5.1.4. Challenges
5.1.4.1. Modalities and Complications Associated With Unmonitored Use of High-Flow Nasal Cannula
5.2. Market Segmentation Analysis
5.2.1. Component: significant adoption of air oxygen blenders to provide critical functionality of precisely adjusting oxygen levels
5.2.2. End User: Growing use of high-flow nasal cannula in hospitals for supporting a wide range of patients and clinical scenarios.
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization
6. High-flow Nasal Cannula Market, by Component
6.1. Introduction
6.2. Active Humidifier
6.3. Air Oxygen Blender
6.4. Heated Inspiratory Circuit
6.5. Nasal Cannula
7. High-flow Nasal Cannula Market, by Indication
7.1. Introduction
7.2. Acute Heart Failure
7.3. Acute Respiratory Failure
7.4. Bronchiectasis
7.5. Carbon Monoxide Toxicity
7.6. Chronic Obstructive Pulmonary Disease
8. High-flow Nasal Cannula Market, by End User
8.1. Introduction
8.2. Ambulatory Care Centers
8.3. Hospitals
8.4. Long-Term Care Centers
9. Americas High-flow Nasal Cannula Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific High-flow Nasal Cannula Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa High-flow Nasal Cannula Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. New Bronchiolitis Trial Launched to Seek The Best Breathing Support For Babies
12.3.2. Telesair Secures FDA Nod For Bonhawa Flow Oxygen Therapy System
12.3.3. Mercy Flights Implementing High-Flow Nasal Cannula for High-Risk Respiratory Illness
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. HIGH-FLOW NASAL CANNULA MARKET RESEARCH PROCESS
FIGURE 2. HIGH-FLOW NASAL CANNULA MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. HIGH-FLOW NASAL CANNULA MARKET DYNAMICS
FIGURE 7. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. HIGH-FLOW NASAL CANNULA MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. HIGH-FLOW NASAL CANNULA MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. HIGH-FLOW NASAL CANNULA MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY ACTIVE HUMIDIFIER, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY ACTIVE HUMIDIFIER, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY AIR OXYGEN BLENDER, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY AIR OXYGEN BLENDER, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY HEATED INSPIRATORY CIRCUIT, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY HEATED INSPIRATORY CIRCUIT, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY NASAL CANNULA, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY NASAL CANNULA, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY ACUTE HEART FAILURE, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY ACUTE HEART FAILURE, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY ACUTE RESPIRATORY FAILURE, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY ACUTE RESPIRATORY FAILURE, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY BRONCHIECTASIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY BRONCHIECTASIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY CARBON MONOXIDE TOXICITY, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY CARBON MONOXIDE TOXICITY, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY LONG-TERM CARE CENTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY LONG-TERM CARE CENTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 38. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 39. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 40. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 41. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 42. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 43. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 44. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 45. ARGENTINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 46. ARGENTINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 47. ARGENTINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 48. ARGENTINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 49. ARGENTINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 50. ARGENTINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 51. BRAZIL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 52. BRAZIL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 53. BRAZIL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 54. BRAZIL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 55. BRAZIL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 56. BRAZIL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 57. CANADA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 58. CANADA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 59. CANADA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 60. CANADA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 61. CANADA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 62. CANADA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 63. MEXICO HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 64. MEXICO HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 65. MEXICO HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 66. MEXICO HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 67. MEXICO HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 68. MEXICO HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 69. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 70. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 71. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 72. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 73. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 74. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 75. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 76. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 78. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 80. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 82. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 84. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 85. AUSTRALIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 86. AUSTRALIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 87. AUSTRALIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 88. AUSTRALIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 89. AUSTRALIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 90. AUSTRALIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 91. CHINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 92. CHINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 93. CHINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 94. CHINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 95. CHINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 96. CHINA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 97. INDIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 98. INDIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 99. INDIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 100. INDIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 101. INDIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 102. INDIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 103. INDONESIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 104. INDONESIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 105. INDONESIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 106. INDONESIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 107. INDONESIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 108. INDONESIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 109. JAPAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 110. JAPAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 111. JAPAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 112. JAPAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 113. JAPAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 114. JAPAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 115. MALAYSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 116. MALAYSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 117. MALAYSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 118. MALAYSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 119. MALAYSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 120. MALAYSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 121. PHILIPPINES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 122. PHILIPPINES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 123. PHILIPPINES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 124. PHILIPPINES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 125. PHILIPPINES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 126. PHILIPPINES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 127. SINGAPORE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 128. SINGAPORE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 129. SINGAPORE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 130. SINGAPORE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 131. SINGAPORE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 132. SINGAPORE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 133. SOUTH KOREA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 134. SOUTH KOREA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 135. SOUTH KOREA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 136. SOUTH KOREA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 137. SOUTH KOREA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 138. SOUTH KOREA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 139. TAIWAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 140. TAIWAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 141. TAIWAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 142. TAIWAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 143. TAIWAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 144. TAIWAN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 145. THAILAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 146. THAILAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 147. THAILAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 148. THAILAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 149. THAILAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 150. THAILAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 151. VIETNAM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 152. VIETNAM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 153. VIETNAM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 154. VIETNAM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 155. VIETNAM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 156. VIETNAM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 165. DENMARK HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 166. DENMARK HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 167. DENMARK HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 168. DENMARK HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 169. DENMARK HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 170. DENMARK HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 171. EGYPT HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 172. EGYPT HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 173. EGYPT HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 174. EGYPT HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 175. EGYPT HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 176. EGYPT HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 177. FINLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 178. FINLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 179. FINLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 180. FINLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 181. FINLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 182. FINLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 183. FRANCE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 184. FRANCE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 185. FRANCE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 186. FRANCE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 187. FRANCE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 188. FRANCE HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 189. GERMANY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 190. GERMANY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 191. GERMANY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 192. GERMANY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 193. GERMANY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 194. GERMANY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 195. ISRAEL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 196. ISRAEL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 197. ISRAEL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 198. ISRAEL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 199. ISRAEL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 200. ISRAEL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 201. ITALY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 202. ITALY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 203. ITALY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 204. ITALY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 205. ITALY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 206. ITALY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 207. NETHERLANDS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 208. NETHERLANDS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 209. NETHERLANDS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 210. NETHERLANDS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 211. NETHERLANDS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 212. NETHERLANDS HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 213. NIGERIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 214. NIGERIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 215. NIGERIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 216. NIGERIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 217. NIGERIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 218. NIGERIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 219. NORWAY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 220. NORWAY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 221. NORWAY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 222. NORWAY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 223. NORWAY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 224. NORWAY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 225. POLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 226. POLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 227. POLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 228. POLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 229. POLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 230. POLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 231. QATAR HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 232. QATAR HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 233. QATAR HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 234. QATAR HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 235. QATAR HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 236. QATAR HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 237. RUSSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 238. RUSSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 239. RUSSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 240. RUSSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 241. RUSSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 242. RUSSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 244. SAUDI ARABIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 246. SAUDI ARABIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 248. SAUDI ARABIA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 250. SOUTH AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 252. SOUTH AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 254. SOUTH AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 255. SPAIN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 256. SPAIN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 257. SPAIN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 258. SPAIN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 259. SPAIN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 260. SPAIN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 261. SWEDEN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 262. SWEDEN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 263. SWEDEN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 264. SWEDEN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 265. SWEDEN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 266. SWEDEN HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 267. SWITZERLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 268. SWITZERLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 269. SWITZERLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 270. SWITZERLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 271. SWITZERLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 272. SWITZERLAND HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 273. TURKEY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 274. TURKEY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 275. TURKEY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 276. TURKEY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 277. TURKEY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 278. TURKEY HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 286. UNITED KINGDOM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 288. UNITED KINGDOM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 290. UNITED KINGDOM HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 291. HIGH-FLOW NASAL CANNULA MARKET SHARE, BY KEY PLAYER, 2023
TABLE 292. HIGH-FLOW NASAL CANNULA MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • Allied Medical Limited
  • Armstrong Medical Limited
  • BMC Medical Co., Ltd.
  • Drägerwerk AG & Co. KGaA
  • Fairmont Medical Products Pty Ltd.
  • Fisher & Paykel Healthcare Corporation Limited
  • Flexicare (Group) Limited
  • Great Group Medical Co., Ltd.
  • Guangdong Pigeon Medical Apparatus Co.,Ltd.
  • Hamilton Medical AG
  • Heka Medicals India Private Limited
  • ICU Medical, Inc.
  • Koninklijke Philips N.V.
  • Masimo Corporation
  • MEKICS Co., Ltd.
  • Narang Medical Limited
  • nice Neotech Medical Systems Pvt. Ltd.
  • ResMed, Inc.
  • Sterimed Group
  • SunMed, LLC
  • Synergy Intact Private Limited
  • Teleflex Incorporated
  • Vapotherm, Inc.
  • Vyaire Medical, Inc.
  • Well Lead Medical Co., Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages192
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 3.38 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.76 Billion
Compound Annual Growth Rate9.1%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

High flow nasal cannula Global Market Report 2024 - Product Image

High flow nasal cannula Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
High-flow Nasal Cannula - Global Strategic Business Report - Product Image

High-flow Nasal Cannula - Global Strategic Business Report

  • Report
  • 182 Pages
  • Global
From
Nasal Cannula Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Nasal Cannula Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 109 Pages
  • Global
From
Global Cannula Market by Product (Arthroscopy Cannulas, Cardiac Cannulas, Dermatology Cannulas), Material (Metal Cannulas, Plastic Cannulas, Silicone Cannulas), Application, End-User - Forecast 2024-2030 - Product Image

Global Cannula Market by Product (Arthroscopy Cannulas, Cardiac Cannulas, Dermatology Cannulas), Material (Metal Cannulas, Plastic Cannulas, Silicone Cannulas), Application, End-User - Forecast 2024-2030

  • Report
  • 183 Pages
  • Global
From
Cannula Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030 - Product Image

Cannula Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030

  • Report
  • 146 Pages
  • Global
From

About the High Flow Nasal Cannula Market

The High Flow Nasal Cannula (HFNC) is a respiratory device used to deliver humidified oxygen or air to a patient. It is a non-invasive form of respiratory support that is used to treat patients with respiratory distress. The device consists of a nasal cannula connected to a flow generator, which is used to regulate the flow of oxygen or air. The device is designed to provide a higher flow rate than traditional nasal cannulas, allowing for improved oxygen delivery and improved patient comfort. HFNC is used in a variety of clinical settings, including emergency departments, intensive care units, and home care settings. It is used to treat a variety of respiratory conditions, including chronic obstructive pulmonary disease, asthma, and acute respiratory distress syndrome. The HFNC market is a rapidly growing segment of the respiratory device market. It is expected to continue to grow as more healthcare providers recognize the benefits of HFNC in treating respiratory conditions. Some companies in the HFNC market include Fisher & Paykel Healthcare, Philips Respironics, Vapotherm, and ResMed. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.